ClinConnect ClinConnect Logo
Search / Trial NCT06953414

Classification and Prediction of Difficult Awake Tracheal Intubation With Flexible Bronchoscopes

Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Apr 29, 2025

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Airway Management Classification Flexible Endoscopy Guided Intubation Fibroptic Guided Intubation Respiratory System Laryngeal Diseases Health Records

ClinConnect Summary

This clinical trial is studying a method called awake tracheal intubation using flexible bronchoscopes, which is a technique used to help patients breathe when there are expected difficulties with their airways. The goal is to create new ways to predict how challenging this procedure might be, both before it starts and after it has been performed. Currently, doctors often rely on older scoring systems that may not be suitable for this specific method. By developing new prediction models and using advanced technology, the researchers hope to improve safety and effectiveness during this important airway management technique.

To participate in this trial, patients must be at least 18 years old and have a known risk for difficult airways, meaning they are likely to need the awake tracheal intubation procedure. Participants will need to give their consent to join the study. Unfortunately, individuals who are pregnant, breastfeeding, or not scheduled for the procedure will not be eligible. If you choose to participate, you can expect to contribute to the development of better tools that could help doctors manage airway difficulties in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with an anticipated difficult airways scheduled for ATI:FB
  • Consent by the patient
  • Minimum 18 years of age
  • Exclusion Criteria:
  • Patients not scheduled for ATI:FB
  • Pregnant or breastfeeding patients
  • Consent not given by the patient

About Universitätsklinikum Hamburg Eppendorf

Universitätsklinikum Hamburg-Eppendorf (UKE) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, UKE integrates state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among top-tier researchers, clinicians, and healthcare professionals. The institution is dedicated to improving patient outcomes by conducting rigorous scientific investigations that address critical health challenges, ultimately contributing to the development of novel therapies and enhancing medical knowledge.

Locations

Hamburg, , Germany

Patients applied

0 patients applied

Trial Officials

Martin Petzoldt, MD, FEAMS

Principal Investigator

University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf

Vera Köhl, MD

Principal Investigator

University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported